Navigation Links
Grant supports study of abnormal ring-shaped chromosomes
Date:10/9/2007

When chromosomes, which are normally bar-shaped, instead bend into a ring before birth, they may disrupt normal development and cause a multitude of problems. Genetics experts at The Childrens Hospital of Philadelphia will be investigating one such disorder, supported by a $126,000 grant from the Ring Chromosome 20 Foundation.

Ring chromosome 20 syndrome, so-called because it affects the 20th of the 23 human chromosomes, often causes a severe form of epilepsy that is difficult to treat. First described in 1972, it is considered relatively rare. The actual prevalence is uncertain, because it may go undiagnosed in some patients with severe epilepsy, says Nancy B. Spinner, Ph.D., a geneticist at Childrens Hospital who leads the new project.

We believe that the abnormal ring shape that occurs in this disorder interferes with the normal function of genes on chromosome 20, leading to the pattern of abnormalities seen in patients, added Dr. Spinner. In addition to epilepsy, the symptoms, manifesting themselves in childhood or adolescence, may include mental retardation, growth disturbances and small head circumference.

The Ring Chromosome 20 program will initially identify patients with the syndrome, establish cell lines and a clinical database, map the chromosome and analyze patterns of gene expression, in building a knowledge foundation for eventually guiding the way to future treatments for the disorder.

Dr. Spinner, the director of the Clinical Cytogenetics Laboratory at Childrens Hospital, previously discovered genes responsible for the genetic disease Alagille syndrome, which affects multiple organs. Childrens Hospital has one of the worlds leading programs for the diagnosis and treatment of genetic diseases in children.

Dr. Spinner will be collaborating with the hospitals new Center for Applied Genomics to better define the molecular defects occurring in ring chromosome 20 syndrome. Established in July 2006, the center is the worlds largest program dedicated to genetic analysis of childhood diseases. After we understand the underlying molecular processes, we hope this will lead to the development of potential treatments for the syndrome, said Dr. Spinner, who is a professor of Human Genetics in Pediatrics at the University of Pennsylvania School of Medicine.


'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Related biology news :

1. Researcher gets NSF grant to create mutant maize lines
2. $6.5 Million Grant for Microarray Center at Yale School of Medicine
3. MSU researchers receive $4 million grant to uncover gene functions
4. Virulizin granted orphan drug status in Europe
5. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
6. Asian immigrants in NYC not receiving HIV education at religious institutions
7. Federal grant funds research on novel HIV therapy
8. Boston University biomedical engineers win major grant for pursuit of the $1,000 Genome
9. Scientists win grants to develop $1,000 genome sequencing technology
10. First Quantum Grant to fund stem cell repair of damage from stroke
11. In presence of fragrant cleaning products, air purifiers that emit ozone can dirty the air
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: